Home Amines 5469-70-5
5469-70-5,MFCD01529869
Catalog No.:AA0033IQ

5469-70-5 | Pyridazin-3-amine

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
98%
in stock  
$11.00   $8.00
- +
5g
98%
in stock  
$16.00   $11.00
- +
10g
98%
in stock  
$19.00   $14.00
- +
15g
95%
in stock  
$26.00   $18.00
- +
100g
98%
in stock  
$159.00   $111.00
- +
  • Technical Information
  • Properties
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Literature
Technical Information
Catalog Number:
AA0033IQ
Chemical Name:
Pyridazin-3-amine
CAS Number:
5469-70-5
Molecular Formula:
C4H5N3
Molecular Weight:
95.1026
MDL Number:
MFCD01529869
SMILES:
Nc1cccnn1
NSC Number:
25228
Properties
Properties
 
BP:
326.19 °C at 760 mmHg  
Form:
Solid  
MP:
171 °C  
Storage:
Keep in dry area;Room Temperature;  

Computed Properties
 
Complexity:
54.9  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
XLogP3:
-1.2  

Literature

Title: Discovery and Characterization of a Highly Potent and Selective Aminopyrazoline-Based in Vivo Probe (BAY-598) for the Protein Lysine Methyltransferase SMYD2.

Journal: Journal of medicinal chemistry 20160526

Title: Competitive antagonism of insect GABA receptors by iminopyridazine derivatives of GABA.

Journal: Bioorganic & medicinal chemistry 20121001

Title: In vivo evaluation of alpha7 nicotinic acetylcholine receptor agonists [11C]A-582941 and [11C]A-844606 in mice and conscious monkeys.

Journal: PloS one 20100101

Title: Polyfunctional nitriles in organic syntheses: a novel route to aminopyrroles, pyridazines and pyrazolo[3,4-c]pyridazines.

Journal: Molecules (Basel, Switzerland) 20090216

Title: A novel and convenient protocol for synthesis of pyridazines.

Journal: Organic letters 20090115

Title: R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond.

Journal: Antiviral research 20080601

Title: Privileged structures: a useful concept for the rational design of new lead drug candidates.

Journal: Mini reviews in medicinal chemistry 20071101

Title: Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries.

Journal: Molecular diversity 20060801

Title: De novo and molecular target-independent discovery of orally bioavailable lead compounds for neurological disorders.

Journal: Current Alzheimer research 20060701

Title: Aminopyridazines attenuate hippocampus-dependent behavioral deficits induced by human beta-amyloid in a murine model of neuroinflammation.

Journal: Journal of molecular neuroscience : MN 20040101

Title: Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.

Journal: Neurobiology of aging 20040101

Title: An aminopyridazine-based inhibitor of a pro-apoptotic protein kinase attenuates hypoxia-ischemia induced acute brain injury.

Journal: Bioorganic & medicinal chemistry letters 20031020

Title: Discovery of new chemical classes of synthetic ligands that suppress neuroinflammatory responses.

Journal: Journal of molecular neuroscience : MN 20020101

Title: Serotonin receptor and transporter ligands - current status.

Journal: Current medicinal chemistry 20010701

Title: Structure-based 3D QSAR and design of novel acetylcholinesterase inhibitors.

Journal: Journal of computer-aided molecular design 20010501

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:5469-70-5 Molecular Formula|5469-70-5 MDL|5469-70-5 SMILES|5469-70-5 Pyridazin-3-amine |Organic_Building_Blocks